Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT03175224 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 497 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Apollomics Inc. |
| Last Updated on CT.gov | June 27, 2025 (Jun 27, 2025) |
As of March 2, 2026: Clinical trial NCT03175224 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Apollomics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03175224 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03175224 was last updated Jun 27, 2025 (June 27, 2025). HelloStudys verifies this status automatically.